This topic contains 0 replies, has 1 voice, and was last updated by 
-
Posts
-
A single dose of Translate Bio’s first-in-class mRNA therapy MRT5005 may improve lung function in cystic fibrosis, interim Phase 1/2 trial data shows. Click here to read more about it.
What are your thoughts about this study and its findings?
You must be logged in to reply to this topic.
